Patents by Inventor Mehdi Paborji

Mehdi Paborji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapy for the treatment of disease
    Patent number: 7666894
    Abstract: Disclosed herein are pharmaceutical compositions comprising oxybutynin, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: February 23, 2010
    Assignee: TheraVida, Inc.
    Inventor: Mehdi Paborji
  • THERAPY FOR THE TREATMENT OF DISEASE
    Publication number: 20090318522
    Abstract: Disclosed herein are pharmaceutical compositions comprising oxybutynin, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.
    Type: Application
    Filed: September 8, 2009
    Publication date: December 24, 2009
    Applicant: THERAVIDA, INC.
    Inventor: Mehdi PABORJI
  • THERAPY FOR THE TREATMENT OF DISEASE
    Publication number: 20090275629
    Abstract: Disclosed herein are pharmaceutical compositions comprising various combinations of an antimuscarinic or an anticholinergic agent, a compound that causes stimulation of salivary glands, and a compound that relieves constipation. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.
    Type: Application
    Filed: July 15, 2009
    Publication date: November 5, 2009
    Applicant: THERAVIDA, INC.
    Inventor: Mehdi Paborji
  • THERAPY FOR THE TREATMENT OF DISEASE
    Publication number: 20070053995
    Abstract: Disclosed herein are pharmaceutical compositions comprising various combinations of an antimuscarinic or an anticholinergic agent, a compound that causes stimulation of salivary glands, and a compound that relieves constipation. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.
    Type: Application
    Filed: August 28, 2006
    Publication date: March 8, 2007
    Applicant: THERAVIDA, LLC
    Inventor: Mehdi Paborji
  • Crystalline beta2 adrenergic receptor agonist
    Publication number: 20050075271
    Abstract: The invention provides a crystalline salt form of a novel ?2 adrenergic receptor agonist. The invention also provides pharmaceutical compositions comprising the crystalline form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt form to treat diseases associated with ?2 adrenergic receptor activity, and processes useful for preparing such a crystalline compound.
    Type: Application
    Filed: July 25, 2003
    Publication date: April 7, 2005
    Inventors: Martin Linsell, John Jacobsen, Davar Khossravi, Mehdi Paborji, Weijiang Zhang
  • Stable solutions of mitomycin C
    Patent number: 5216011
    Abstract: A stable solution of mitomycin C in propylene glycol or propylene glycol/water is disclosed. The solutions have an acceptable shelf-life of greater than 24 months at 4.degree. C. and can be injected directly or diluted with water or other aqueous parenteral vehicle for parenteral administration.
    Type: Grant
    Filed: September 1, 1989
    Date of Patent: June 1, 1993
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Mehdi Paborji, Joseph B. Bogardus, Shreeram N. Agharkar, William P. Coppola